Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	8.41	7.11	7.83	8.54	3.19	1.13
Cash & Short-Term Investments	8.41	7.11	7.83	8.54	3.19	1.13
Cash Growth	-7.38%	-9.27%	-8.24%	167.33%	182.11%	-50.31%
Receivables	20.49	19.45	3.09	3.06	3.5	4.11
Inventory	13.83	12.93	9.55	6.74	5.01	4.14
Prepaid Expenses	0.44	0.52	1.03	0.53	0.49	0.87
Total Current Assets	43.16	40.01	21.51	18.86	12.19	10.25
Property, Plant & Equipment	14.77	14.61	10.44	6.98	6.86	7.59
Other Intangible Assets	0.29	0.29	0.29	0.47	0.47	0.47
Long-Term Deferred Tax Assets	22.14	22.16	2.17	2.17	-	-
Long-Term Deferred Charges	6.95	6.05	6.05	6.17	6.17	6.17
Other Long-Term Assets	0.53	0.53	0.43	0.5	0.5	0.48
Total Assets	87.85	83.65	40.9	35.15	26.19	24.96
Accounts Payable	2.61	2.71	2.45	1.43	0.93	1.58
Accrued Expenses	5.53	4.82	4.63	4.28	4.27	4.82
Short-Term Debt	4	4	-	-	-	-
Current Portion of Long-Term Debt	0.43	0.3	0.31	0.35	0.41	1.85
Current Portion of Leases	0.74	0.72	0.01	0.2	0.19	0.21
Current Income Taxes Payable	0.7	0.49	0.41	0.41	-	-
Current Unearned Revenue	0.01	0.01	0.01	0.01	0.01	0.18
Total Current Liabilities	14.01	13.05	7.83	6.69	5.81	8.64
Long-Term Debt	3.24	3.28	3.56	1.39	1.74	1.8
Long-Term Leases	3.25	3.44	-	0.84	0.04	0.17
Long-Term Unearned Revenue	0	0.01	0.02	0.03	0.05	0.06
Other Long-Term Liabilities	9.08	6.3	0.52	0.98	2.4	3.63
Total Liabilities	29.6	26.07	11.94	9.93	10.04	14.3
Common Stock	1.07	1.07	1.01	1.01	1.01	0.84
Additional Paid-In Capital	173.26	173.21	164.75	164.58	164.41	150.26
Retained Earnings	-115.77	-116.39	-136.5	-140.06	-148.96	-154.05
Treasury Stock	-0.31	-0.31	-0.31	-0.31	-0.31	-0.31
Total Common Equity	58.25	57.58	28.96	25.22	16.15	-3.25
Shareholders' Equity	58.25	57.58	28.96	25.22	16.15	10.66
Total Liabilities & Equity	87.85	83.65	40.9	35.15	26.19	24.96
Total Debt	11.66	11.74	3.89	2.78	2.38	4.03
Net Cash (Debt)	-3.26	-4.63	3.94	5.75	0.81	-2.9
Net Cash Growth	-	-	-31.44%	606.63%	-	-
Net Cash Per Share	-0.00	-0.00	0.00	0.01	0.00	-0.00
Filing Date Shares Outstanding	1,068	1,068	1,014	1,011	1,009	840.4
Total Common Shares Outstanding	1,068	1,068	1,014	1,011	1,009	840.4
Working Capital	29.15	26.96	13.68	12.17	6.38	1.61
Book Value Per Share	0.05	0.05	0.03	0.02	0.02	-0.00
Tangible Book Value	57.96	57.29	28.67	24.76	15.69	-3.71
Tangible Book Value Per Share	0.05	0.05	0.03	0.02	0.02	-0.00
Land	11.61	11.06	10.77	5.46	5.46	5.26
Machinery	15.16	15.02	14.24	13.85	13.35	12.92

Source: S&P Capital IQ. Standard template. Financial Sources.